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Abstract
Recently, genome-wide association studies of breast cancer
revealed single nucleotide polymorphisms (SNPs) in five genes
with novel association to susceptibility. While there is little doubt
that the novel susceptibility markers produced from such highly
powered studies are true, the mechanisms by which they cause
the susceptibility remain undetermined. We have looked at the
expression levels of the identified genes in tumours and found that
they are highly significantly differentially expressed between the
five established breast cancer subtypes. Also, a significant
association between SNPs in these genes and their expression in
tumours was seen as well as a significantly different frequency of
the SNPs between the subtypes. This suggests that the observed
genes are associated with different breast cancer subtypes, and
may exert their effect through their expression in the tumours. Thus,
future studies stratifying patients by their molecular subtypes may
give much more power to classic case control studies, and genes
of no or borderline significance may appear to be high-penetrant
for certain subtypes and, therefore, be identifiable.
A genome-wide association study of breast cancer has
revealed single nucleotide polymorphisms (SNPs) in five
genes with novel association to susceptibility: TNRC9,
FGFR2, MAP3K1, H19  and LSP1 [1]. The results were
confirmed for FGFR2 and  TNRC9 in two independent
studies [2,3]. However, these studies revealed little of the
mechanisms underlying these associations. Pooling of such a
large amount of cases, as performed in these studies,
inevitably leads to concealment of the various histological and
clinico-pathological subtypes. This suggests that the
observed genes are either of universal importance for breast
cancer development, are associated with a subgroup that
dominates the overall pool or are associated with any
subgroup but with an association sufficiently strong to
dominate the overall result. Breast cancer patients can be
divided into five distinct molecular subtypes based on their
expression profiles [4]. The existence of these five subtypes,
luminal A, luminal B, basal-like, ErbB2+, and normal-like, have
been confirmed in independent datasets [5] and they are
associated with different clinical outcomes [6]. If the
probability to develop a given subtype of breast cancer is
genetically determined, we might expect to find that the newly
discovered susceptibility genes [1] are differentially
expressed in the various tumour subtypes, and that their
transcription is regulated in cis by SNPs within them. With
this in mind, we retrieved the mRNA expression data of
TNRC9, FGFR2, MAP3K1, H19 and LSP1 from 112 breast
tumours representing all five subtypes [7]. Significantly
different mRNA levels between the subtypes were found for
all the five genes by ANOVA analysis (Table 1). For instance,
TNRC9 was up-regulated in luminal A, luminal B and ErbB2+
subtypes and down-regulated in the basal-like subtype
(p = 4.5 × 10-7). FGFR2 was up-regulated in luminal A and
basal-like subtypes and down-regulated in luminal B and
ErbB2+ subtypes (p = 3.1 × 10-5), while MAP3K1  was up-
regulated in luminal A and the normal-like subtypes and
down-regulated in luminal B, ErbB2+ and basal-like subtypes
(p = 5.2 × 10-5). Furthermore, we could calculate the associa-
tion between SNPs residing within these genes and their
tumour expression levels since genotype data on these
patients have been generated using an Illumina 109K SNP
array. The three genes whose expression levels were most
significantly associated with tumour subtype (TNRC9,
FGFR2  and MAP3K1) all harboured SNPs within them
displaying a significant association with gene expression level
(Table 1). One of these SNPs, rs9940048 in TNRC9,
displayed a significantly different genotype distribution
between the subtypes, with breast cancer patients homo-
zygous for the low frequency allele over-represented in the
basal-like subtype (p = 0.003), in concordance with the
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observation that the basal-like tumours had the lowest levels
of TNRC9 mRNA.
Conclusions
Our results suggest that SNPs in the recently discovered
susceptibility genes may exert their effect through the
expression of their genes in tumours, giving rise to the various
breast cancer subtypes. Thus, stratification of patients by
their molecular subtypes may give much more power to
classic case control studies, and genes of no or borderline
significance may appear to be high-penetrant for certain
subtypes and, therefore, be identifiable.
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Table 1
P-values after ANOVA analyses 
Gene Clone ID SNP ID Exp vs subtypea SNP vs Expb SNP vs subtypec
TNRC9 IMAGE:2139448 rs9940048 4.5 × 10-7 0.043 0.003
FGFR2 IMAGE:809464 rs2981451 3.1 × 10-5 0.035 0.875
MAP3K1 IMAGE:810230 rs831818 5.2 × 10-5 0.0045 0.779
H19 IMAGE:428721 rs2839701 0.001 0.268 0.082
LSP1 IMAGE:110788 rs661348 0.005 0.840 0.56
aExpression levels of the five genes (clone ID) between the various subgroups. bSingle nucleotide polymorphisms (SNP ID) versus expression of
the five genes. cGenotype distribution of SNPs (SNP ID) between the various subgroups.